Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections

Patients affected by acute coronary syndrome (ACS) or by chronic inflammatory musculoskeletal and connective tissue diseases (i.e. systemic sclerosis), often need antiaggregant therapy (ASA or Clopidogrel). The concomitant use of proton pump inhibitors (PPIs) is suggested to reduce the risk of haemo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: E. Gremese (VerfasserIn), A. Zoli (VerfasserIn), A. Laria (VerfasserIn), G.F. Ferraccioli (VerfasserIn)
Format: Buch
Veröffentlicht: PAGEPress Publications, 2011-06-01T00:00:00Z.
Schlagworte:
Online-Zugang:Connect to this object online.
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d0263f99da9049ab9404b0feaddc907d
042 |a dc 
100 1 0 |a E. Gremese  |e author 
700 1 0 |a A. Zoli  |e author 
700 1 0 |a A. Laria  |e author 
700 1 0 |a G.F. Ferraccioli  |e author 
245 0 0 |a Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections 
260 |b PAGEPress Publications,   |c 2011-06-01T00:00:00Z. 
500 |a 10.4081/reumatismo.2011.5 
500 |a 0048-7449 
500 |a 2240-2683 
520 |a Patients affected by acute coronary syndrome (ACS) or by chronic inflammatory musculoskeletal and connective tissue diseases (i.e. systemic sclerosis), often need antiaggregant therapy (ASA or Clopidogrel). The concomitant use of proton pump inhibitors (PPIs) is suggested to reduce the risk of haemorrhage. Clopidogrel is a prodrug activated by cytocrome P 450. PPIs too have a CYP P450 metabolism, and a drug interaction has been observed between PPIs and clopidogrel. 25% of nonresponsiveness to clopidogrel is due to this drug interaction (1). Some studies have demonstrated that the use of PPIs is associated with an increased risk of bone fractures and Clostridium difficile infection. 
546 |a EN 
546 |a IT 
690 |a Medicine 
690 |a R 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n Reumatismo, Vol 63, Iss 1, Pp 5-10 (2011) 
787 0 |n http://www.reumatismo.org/index.php/reuma/article/view/504 
787 0 |n https://doaj.org/toc/0048-7449 
787 0 |n https://doaj.org/toc/2240-2683 
856 4 1 |u https://doaj.org/article/d0263f99da9049ab9404b0feaddc907d  |z Connect to this object online.